 Methods This is a randomized clinical placebo-controlled double-blinded crossover trial. A group of healthy men will be randomized to either 4 weeks treatment with the drug Kaleorid, 750mg, 3 tablets 3 times daily or to 4 weeks treatment with placebo. 